Concert Pharmaceuticals, Inc. Deferred Offering Costs
Concert Pharmaceuticals, Inc. had Deferred Offering Costs of $15.00 thousand as of 2021-12-31, per its 10-K filed 2022-03-03.
Discontinued › Balance Sheet › Assets › Assets, Current › Deferred Costs, Current
us-gaap:DeferredOfferingCosts · last filed 2022-03-03
- 2021-12-31: Deferred Offering Costs $15.00K.
- 2020-12-31: Deferred Offering Costs $0.00.
- 2019-12-31: Deferred Offering Costs $143.00K.
- 2018-12-31: Deferred Offering Costs $0.00.
| Period end | Deferred Offering Costs |
|---|---|
| 2021-12-31 | $15.00K 10-K · filed 2022-03-03 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-03 |
| 2019-12-31 | $143.00K 10-K · filed 2021-02-25 |
| 2018-12-31 | $0.00 10-K · filed 2020-02-27 |